Abstract
Objectives: Infections of vulva and vagina are commonly encountered in gynecology practice. These infections are predominant in the women of reproductive age group so, this study was done to determine the prevalence of vaginal candidiasis and identify, differentiate Candida species isolated from the patients. Three high vaginal swabs per patients were collected using sterile cotton-tipped swabs from Gynecology Department and processed in Department of Microbiology, MLBMC, India. Candida was identified using standard guidelines. The study was done on 350 women in reproductive age group (18–49 years), 63.4% were non-pregnant and 36.5% pregnant. One hundred and sixteen/350 (33.1%) samples showed pure growth of Candida species. Candida positivity among pregnant women (42.9%) was higher than in non-pregnant women (27.1%). Isolation of non-albican Candida was higher (26.7%) than Candida albicans, this difference was statistically significant (p<0.05) The most common isolated species by conventional methods was C. albicans (36.3%) followed by Candida glabrata (24.1%), Candida tropicalis (22.5%), Candida krusei (10.3), and Candida parapsilosis (7.7%). In case of C. albicans, Fluconazole and Amphotericin B were found to be most sensitive drugs followed by Nystatin, voriconazole and ketoconazole and among non-albicans candida, Nystatin was the highly sensitive drug. Vulvovaginal candidiasis (VCC) is the most common infection in the women reproductive age group. Several predisposing factors such as HIV, diabetes mellitus, oral contraceptive, IUCD usage, antibiotics, and immunosuppressive drug increase the VCC, C. albicans was the most prevalent species followed by C. glabrata and C. tropicalis.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference22 articles.
1. Jeanmonod R, Jeanmonod D. Vaginal Candidiasis (Vulvovaginal Candidiasis). Treasure Island, (FL): Stat Pearls Publishing; 2020.
2. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: Epidemiological, diagnostic and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-11. doi: 10.1016/ s0002-9378(98)80001-x, PMID 9500475
3. Nyirjesy P. Vulvovaginal candidiasis and bacterial vaginosis. Infect Dis Clin North Am 2008;22:637-52. doi: 10.1016/j.idc.2008.05.002, PMID 18954756
4. Kumari V, Banerjee T, Kumar P, Pandey S, Tilak R. Emergence of non- albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors from a tertiary care center, North India. Indian J Pathol Microbiol 2013;56:144-7. doi: 10.4103/0377- 4929.118703, PMID 24056652
5. Kalia N, Singh J, Sharma S, Kamboj SS, Arora H, Kaur M. Prevalence of vulvovaginal infections and species-specific distribution of vulvovaginal candidiasis in married women of north India. Int J Curr Microbiol Appl Sci 2015;4:253-66.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献